#USA #CEFALY Technology #Darien #Migraine Treatment #CEFALY@Work

CEFALY Technology Launches CEFALY@Work: A New Solution for Employees with Migraines

In a recent announcement, CEFALY Technology introduced its latest initiative, CEFALY@Work, aimed at providing essential support for employees struggling with migraines. This groundbreaking program is designed to help businesses not only mitigate the negative impact of migraines on their workforce but also enhance overall workplace wellness.

Understanding the Workplace Challenges Caused by Migraines

Migraine is more than just a headache; it is a debilitating neurological disorder affecting a significant portion of the population. Approximately 1 in 5 women and 1 in 7 employees in general suffer from migraines, leading to an average of more than four lost workdays per affected individual each year. This statistic places migraine within the top five causes of long-term disability, showcasing its real consequences on productivity and employee well-being.

Employees afflicted by migraines often face challenges that extend beyond just the physical pain. The disorder can induce symptoms such as nausea, fatigue, light and sound sensitivity, which can substantially diminish a person's work performance. Research indicates that during a migraine attack, employees report being only 46% effective in their tasks, yet many feel compelled to work through their pain due to stigma and fear of judgment related to their condition.

Jen Trainor-McDermott, CEO of CEFALY Technology, addresses these issues directly, stating, "Migraine silently erodes productivity, retention, and morale. It's time we treat it like the workplace issue it truly is — and that's why we've launched CEFALY@Work."

The CEFALY@Work Solution

The core of the CEFALY@Work initiative revolves around offering CEFALY, an FDA-cleared, drug-free wearable device clinically proven to alleviate migraines. It avoids the undesirable side effects commonly associated with traditional migraine medications, such as mental fogginess, making it a preferred choice among patients. The device is currently utilized by over 200,000 patients and is trusted across numerous U.S. VA hospitals. According to Trainor-McDermott, "CEFALY benefits employers because it helps employees with migraine reach their fullest potential — and lowers the costs of care, compared to prescription medications or long-term disability claims."

To ensure maximum accessibility, CEFALY@Work operates on a three-tiered structure:
1. Starter Tier: Employees receive discounts on CEFALY devices.
2. Premium Tier: Employees can acquire a CEFALY device and companion electrodes at no charge from their employers.
3. Enterprise Tier: This includes additional device usage insights, onboarding webinars, and comprehensive support tools.

All tiers will provide custom-branded educational materials tailored to workplace wellness, alongside free access to a CEFALY Coach who will assist employees in making the most of their treatment and managing stress.

A Call to Action for Organizations

CEFALY Technology is currently in the pilot phase of the CEFALY@Work program and is actively looking for U.S.-based companies to partner with for its implementation. Organizations interested in this innovative approach to workplace wellness can learn more and get involved to create a supportive environment for employees affected by migraines.

About CEFALY Technology

Founded in Belgium, CEFALY Technology specializes in creating advanced electronics for medical applications, particularly focusing on improving the lives of individuals with migraines. The company's mission is to continuously innovate in the medical space, empowering migraine sufferers to manage their condition effectively and lead healthier, happier lives. To find out more about CEFALY, visit CEFALY.com and follow them on social media platforms for updates on their initiatives.